Pasar al contenido principal

OPTIMIZACION DE HERRAMIENTAS DE EDICION GENETICA CON UN OBJETIVO TERAPEUTICO

PID2021-127644OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

Identification of the EH CRISPR-Cas9 system on a metagenome and its application to genome engineering

  • Esquerra, Belén
  • Baquedano, Ignacio
  • Ruiz, Raul
  • Fernandez, Almudena
  • Montoliu, Lluis
  • Mojica, Francisco J.M.
  • Mojica, Francisco J.M.|||/items/f14a8472-85f4-48a8-bb8d-3ee259963240
Non-coding RNAs (crRNAs) produced from clustered regularly interspaced short palindromic repeats (CRISPR) loci and CRISPR-associated (Cas) proteins of the prokaryotic CRISPR-Cas systems form complexes that interfere with the spread of transmissible genetic elements through Cas-catalysed cleavage of foreign genetic material matching the guide crRNA sequences. The easily programmable targeting of nucleic acids enabled by these ribonucleoproteins has facilitated the implementation of CRISPR-based molecular biology tools for in vivo and in vitro modification of DNA and RNA targets. Despite the diversity of DNA-targeting Cas nucleases so far identified, native and engineered derivatives of the Streptococcus pyogenes SpCas9 are the most widely used for genome engineering, at least in part due to their catalytic robustness and the requirement of an exceptionally short motif (5′-NGG-3′ PAM) flanking the target sequence. However, the large size of the SpCas9 variants impairs the delivery of the tool to eukaryotic cells and smaller alternatives are desirable. Here, we identify in a metagenome a new CRISPR-Cas9 system associated with a smaller Cas9 protein (EHCas9) that targets DNA sequences flanked by 5′-NGG-3′ PAMs. We develop a simplified EHCas9 tool that specifically cleaves DNA targets and is functional for genome editing applications in prokaryotes and eukaryotic cells.
RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

Evolution of CRISPR-associated endonucleases as inferred from resurrected proteins

  • Alonso-Lerma, Borja
  • Jabalera, Ylenia
  • Samperio, Sara
  • Morin, Matias
  • Fernandez, Almudena
  • Hille, Logan T.
  • Silverstein, Rachel A.
  • Quesada-Ganuza, Ane
  • Reifs, Antonio
  • Fernández-Peñalver, Sergio
  • Benitez, Yolanda
  • Soletto, Lucia
  • Gavira, Jose A.
  • Diaz, Adrian
  • Vranken, Wim
  • Sanchez-Mejias, Avencia
  • Güell, Marc
  • Mojica, Francisco J.M.
  • Kleinstiver, Benjamin P.
  • Moreno-Pelayo, Miguel A.
  • Montoliu, Lluis
  • Perez-Jimenez, Raul
  • Mojica, Francisco J.M.|||/items/f14a8472-85f4-48a8-bb8d-3ee259963240
Clustered regularly interspaced short palindromic repeats (CRISPR)-associated Cas9 is an effector protein that targets invading DNA and plays a major role in the prokaryotic adaptive immune system. Although Streptococcus pyogenes CRISPR–Cas9 has been widely studied and repurposed for applications including genome editing, its origin and evolution are poorly understood. Here, we investigate the evolution of Cas9 from resurrected ancient nucleases (anCas) in extinct firmicutes species that last lived 2.6 billion years before the present. We demonstrate that these ancient forms were much more flexible in their guide RNA and protospacer-adjacent motif requirements compared with modern-day Cas9 enzymes. Furthermore, anCas portrays a gradual palaeoenzymatic adaptation from nickase to double-strand break activity, exhibits high levels of activity with both single-stranded DNA and single-stranded RNA targets and is capable of editing activity in human cells. Prediction and characterization of anCas with a resurrected protein approach uncovers an evolutionary trajectory leading to functionally flexible ancient enzymes.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Evolution of CRISPR-associated endonucleases as inferred from resurrected proteins

  • Alonso-Lerma, Borja
  • Jabalera, Ylenia
  • Samperio, Sara
  • Morin, Matías
  • Fernández, Almudena
  • Hille, Logan T.
  • Silverstein, Rachel A.
  • Quesada-Ganuza, Ane
  • Reifs, Antonio
  • Fernández-Peñalver, Sergio
  • Benitez, Yolanda
  • Soletto, Lucia
  • Gavira, Jose A.
  • Diaz, Adrian
  • Vranken, Wim
  • Sánchez-Mejías, Avencia
  • Güell, Marc
  • Mójica, Francisco J. M.
  • Kleinstiver, Benjamin P.
  • Moreno-Pelayo, Miguel Ángel
  • Montoliu, Lluís
  • Pérez-Jiménez, Raúl
Extended data is available for this paper at https://doi.org/10.1038/s41564-022-01265-y. Supplementary information The online version contains supplementary material available at https://doi.org/10.1038/s41564-022-01265-y., Clustered regularly interspaced short palindromic repeats (CRISPR)-associated Cas9 is an effector protein that targets invading DNA and plays a major role in the prokaryotic adaptive immune system. Although Streptococcus pyogenes CRISPR-Cas9 has been widely studied and repurposed for applications including genome editing, its origin and evolution are poorly understood. Here, we investigate the evolution of Cas9 from resurrected ancient nucleases (anCas) in extinct firmicutes species that last lived 2.6 billion years before the present. We demonstrate that these ancient forms were much more flexible in their guide RNA and protospacer-adjacent motif requirements compared with modern-day Cas9 enzymes. Furthermore, anCas portrays a gradual palaeoenzymatic adaptation from nickase to double-strand break activity, exhibits high levels of activity with both single-stranded DNA and single-stranded RNA targets and is capable of editing activity in human cells. Prediction and characterization of anCas with a resurrected protein approach uncovers an evolutionary trajectory leading to functionally flexible ancient enzymes., This work has been supported by grant nos. PID2019-109087RB-I00 (to R.P.-J.) and RTI2018-101223-B-I00 and PID2021-127644OB-I00 (to L.M.) from the Spanish Ministry of Science and Innovation. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 964764 (to R.P.-J.). The content presented in this document represents the views of the authors, and the European Commission has no liability in respect to the content. We acknowledge financial support from the Spanish Foundation for the Promotion of Research of Amyotrophic Lateral Sclerosis. A.F. acknowledges Spanish Center for Biomedical Network Research on Rare Diseases (CIBERE) intramural funds (no. ER19P5AC756/2021). F.J.M.M. acknowledges research support by Conselleria d’Educació, Investigació, Cultura i Esport from Generalitat Valenciana, research project nos. PROMETEO/2017/129 and PROMETEO/2021/057. M.M. acknowledges funding from CIBERER (grant no. ER19P5AC728/2021). The work has received funding from the Regional Government of Madrid (grant no. B2017/BMD3721 to M.A.M.-P.) and from Instituto de Salud Carlos III, cofounded with the European Regional Development Fund ‘A way to make Europe’ within the National Plans for Scientific and Technical Research and Innovation 2017–2020 and 2021–2024 (nos. PI17/1659, PI20/0429 and IMP/00009; to M.A.M.-P. B.P.K. was supported by an MGH ECOR Howard M. Goodman Award and NIH P01 HL142494., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Identification of the EH CRISPR-Cas9 system on a metagenome and its application to genome engineering

  • Esquerra-Ruvira, Belen
  • Baquedano, Ignacio
  • Ruiz, Raul
  • Fernández, Almudena
  • Montoliu, Lluís
  • Mojica, Francisco J M
Non-coding RNAs (crRNAs) produced from clustered regularly interspaced short palindromic repeats (CRISPR) loci and CRISPR-associated (Cas) proteins of the prokaryotic CRISPR-Cas systems form complexes that interfere with the spread of transmissible genetic elements through Cas-catalysed cleavage of foreign genetic material matching the guide crRNA sequences. The easily programmable targeting of nucleic acids enabled by these ribonucleoproteins has facilitated the implementation of CRISPR-based molecular biology tools for in vivo and in vitro modification of DNA and RNA targets. Despite the diversity of DNA-targeting Cas nucleases so far identified, native and engineered derivatives of the Streptococcus pyogenes SpCas9 are the most widely used for genome engineering, at least in part due to their catalytic robustness and the requirement of an exceptionally short motif (5'-NGG-3' PAM) flanking the target sequence. However, the large size of the SpCas9 variants impairs the delivery of the tool to eukaryotic cells and smaller alternatives are desirable. Here, we identify in a metagenome a new CRISPR-Cas9 system associated with a smaller Cas9 protein (EHCas9) that targets DNA sequences flanked by 5'-NGG-3' PAMs. We develop a simplified EHCas9 tool that specifically cleaves DNA targets and is functional for genome editing applications in prokaryotes and eukaryotic cells., Conselleria de Innovación, Universidades, Ciencia y Sociedad Digital, Generalitat Valenciana (CIUCSD), Grant/Award Numbers: PROMETEO/2017/129 and PROMETEO/2021/057. Ministerio de Ciencia e Innovación (MICINN), Grant/Award Numbers: RTI2018- 101223-B-I00 and PID2021-127644OB-I00., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Affordable Pricing of CRISPR Treatments is a Pressing Ethical Imperative

  • Rueda, Jon
  • de Miguel Beriain, Íñigo
  • Montoliu, Lluís
Casgevy, the world's first approved CRISPR-based cell therapy, has been priced at $2.2 million per patient. Although this hefty price tag was widely anticipated, the extremely high cost of this and other cell and gene therapies poses a major ethical issue in terms of equitable access and global health. In this Perspective, we argue that lowering the prices of future CRISPR therapies is an urgent ethical imperative. Although we focus on Casgevy as a case study, much of our analysis can be extrapolated to the controversies over affordable access to other gene and cell therapies. First, we explain why this first-of-its-kind CRISPR therapy might be so expensive. We then analyze the ethical issues of equity and global health of early CRISPR treatments. Next, we discuss potential solutions to lower the prices of CRISPR gene therapies. We conclude that the approval of CRISPR transforms our obligations of justice and compels us to bring future gene therapies to the maximum possible number of patients with serious genetic diseases at affordable prices., J.R. thanks funding from a U.S.-Spain Fulbright grant, an INPhINIT Retaining Fellowship of the La Caixa Foundation (Grant number LCF/BQ/DR20/11790005), Conselho Nacional de Desenvolvimento Cientíco e Tecnológico (421523/2022-0 and 421419/2023-7) and the Sabadell Foundation. IDM acknowledges the support of the Basque Government, Ayudas a grupos de investigación, Grupo de Investigación IT 1541-22, and research project GODAS, PID2022-137140OB-I00, funded by MCIN/AEI/10.13039/501100011033/FEDER,UE. LM acknowledges the support of the Spanish Ministry of Science and Innovation under PID2021-127644OB-I00, CIBERER and Fundación Ramón Areces., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Ethical aspects associated with genome alteration techniques applied to animal reproduction research

  • Montoliu, Lluís
The revolution in biology triggered by the different genome-editing tools has of course arrived to the research field of animal reproduction. Yeast meganucleases, zinc-finger nucleases, TALEN and, particularly, the several generations of CRISPR tools have landed in animal reproduction thereby providing novel strategies to optimize or modify some of the features and capabilities of the recipient animals. All these genome-editing proposals and activities are associated with ethical considerations regarding how those planned genome alterations might affect important animal welfare issues. The ethical dimension of all these genome editing must be seriously considered. Hence, all ethical aspects bound to any given genome-edited allele in animals should be discussed in order to ensure that we are maximizing benefits and reducing any potential risk or negative considerations of these modifications. In this review, I will summarize some of the experiments reported aiming to investigate or improve animal reproduction and I will address the ethics issues that should also be considered., Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación MCIN/ AEI/10.13039/501100011033/FEDER, UE, Grant/Award Number: PID2021-127644OB, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A Dominant Mutation in Gαs-Protein Increases Hair Pigmentation

  • Goff, Philip S
  • Budd, Peter
  • Logan, Darren W
  • Keighren, Margaret
  • Cantero, Marta
  • McKie, Lisa
  • Montoliu, Lluís
  • Jackson, Ian J
  • Sviderskaya, Elena V
We have identified a chemically induced mouse mutation which increases the eumelanic hair pigmentation. We identify a coding mutation, A3533G, resulting in an amino acid substitution Y1133C, in the Gnas gene encoding the Gαs subunit of the tripartite G-protein, consistent with an activation of signalling via MC1R. In addition heterozygous mutant females are significantly lighter than wild type littermates. In cultured melanocytes, derived from mutant mice crossed to C57BL6 mice carrying Cdkn2atm1Rdp, basal pigmentation is higher than wild type melanocytes derived from litter mates. However, the addition of exogenous NDP-MSH does not increase pigmentation in mutant melanocytes in contrast to the pigmentation response of non-mutant melanocytes. The mutant and wild type cells respond in the same way to agouti signalling protein (ASP), consistent with ASP signalling mediated through a pathway other than Gαs-protein., This work was supported by Medical Research Council, MC_UU_00007/4; Wellcome Trust, 108429/Z/15/Z; Spanish Ministry of Science and Innovation, PID2021-127644OB-I00., Peer reviewed